Embryo Developmental Capacity After Egg Banking in an Ovum Donation Program

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status and phase: Completed; Phase 4

Conditions: Infertility

Treatments: Other: IVF; Other: Oocyte Vitrification

Study type: Interventional

Funder types: Other

Identifiers

NCT00977821

0901-F-054-CS

Details and patient eligibility

About

For an efficient "egg banking" system, an equally efficient cryopreservation strategy that ensures the viability of the oocytes is required. Very recently, improved and new methods are yielding satisfactory results. In particular, vitrification is providing excellent results for both survival and clinical outcomes. However, to evaluate the over all out come there are other parameters to be considered. In this sense, capacity development of embryos generated after oocyte vitrification is a major factor when assessing the viability of vitrified oocytes. Accordingly, the evaluation of the capacity of vitrified oocytes to reach the blastocyst stage will be highly valuable to fully assess the effectiveness of the "egg banking" and its contribution to ovum donation programs.

The aim of this study is to evaluate the developmental capacity of vitrified oocytes by their ability to reach the blastocyst stage. The study includes oocyte donation cycles conducted with vitrified versus fresh oocytes.

Enrollment: 625 patients

Sex: Female

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18-35 year old
• Normal response (8-15 follicles) to long protocol of ovarian stimulation with hCG
• Donors with normal menstrual cycles (21-35 day duration)
• Donors with BMI between 18-25 Kg/m2

Exclusion criteria

• Donors with two or more previous miscarriages
• Polycystic ovary syndrome
• Donors with antecedents of poor embrionary quality not attributed to masculine factor
• Donors with drop of estradiol of more than 10% or estradiol plateau.
• Donors with a high response>20 oocytes and or levels above 3000pg/ml of estradiol the day of the administration of chorionic gonadotrophin (hCG)

Trial design

625 participants in 2 patient groups

fresh

Active Comparator group

Description:

Embryo transfer with fresh oocytes

Treatment:

Other: IVF

Frozen

Experimental group

Description:

Embryo transfer with vitrified oocytes

Treatment:

Other: Oocyte Vitrification